Cargando…

The identification of TCF1(+) progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade

T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) is a rare and aggressive variant of diffuse large B-cell lymphoma (DLBCL) that usually affects young to middle-aged patients, with disseminated disease at presentation. The tumor microenvironment (TME) plays a key role in THRLBCL due to its pecu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabanelli, Valentina, Melle, Federica, Motta, Giovanna, Mazzara, Saveria, Fabbri, Marco, Agostinelli, Claudio, Calleri, Angelica, Del Corvo, Marcello, Fiori, Stefano, Lorenzini, Daniele, Cesano, Alessandra, Chiappella, Annalisa, Vitolo, Umberto, Derenzini, Enrico, Griffin, Gabriel K., Rodig, Scott J., Vanazzi, Anna, Sabattini, Elena, Tarella, Corrado, Sapienza, Maria Rosaria, Pileri, Stefano A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2022
Materias:	Immunobiology and Immunotherapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636403/ https://www.ncbi.nlm.nih.gov/pubmed/35767735 http://dx.doi.org/10.1182/bloodadvances.2022007046

Ejemplares similares

A three-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma
por: Derenzini, Enrico, et al.
Publicado: (2020)

Peripheral T-Cell Lymphoma, Not Otherwise Specified: Clinical Manifestations, Diagnosis, and Future Treatment
por: Pileri, Stefano A., et al.
Publicado: (2021)

Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma
por: Rossi, Alessandra, et al.
Publicado: (2021)

Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects
por: Sapienza, Maria Rosaria, et al.
Publicado: (2019)

Diurnal Expression of PD-1 on Tumor-Associated Macrophages Underlies the Dosing Time-Dependent Antitumor Effects of the PD-1/PD-L1 Inhibitor BMS-1 in B16/BL6 Melanoma-Bearing Mice
por: Tsuruta, Akito, et al.
Publicado: (2022)

Plasmablastic lymphoma: one or more tumors?
por: Pileri, Stefano A., et al.
Publicado: (2021)

Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas
por: Pileri, Stefano A., et al.
Publicado: (2021)

Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL
por: Mazzara, Saveria, et al.
Publicado: (2022)

High frequency of CD4(+)FoxP3(+) cells in HTLV-1 infection: inverse correlation with HTLV-1–specific CTL response
por: Toulza, Frederic, et al.
Publicado: (2008)

The host genomic environment of the provirus determines the abundance of HTLV-1–infected T-cell clones
por: Gillet, Nicolas A., et al.
Publicado: (2011)

SATB1 dictates expression of multiple genes including IL-5 involved in human T helper cell differentiation
por: Ahlfors, Helena, et al.
Publicado: (2010)

Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified
por: Laginestra, Maria Antonella, et al.
Publicado: (2019)

Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified
por: Laginestra, Maria Antonella, et al.
Publicado: (2019)

Dissecting diffuse large B-cell lymphomas of the “not otherwise specified” type: the impact of molecular techniques
por: Pileri, Stefano A, et al.
Publicado: (2018)

Critical but divergent roles for CD62L and CD44 in directing blood monocyte trafficking in vivo during inflammation
por: Xu, Heping, et al.
Publicado: (2008)

Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia
por: Ward, Frank J., et al.
Publicado: (2008)

Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP
por: Bystrom, Jonas, et al.
Publicado: (2008)

Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis
por: Meyer-Bahlburg, Almut, et al.
Publicado: (2008)

Activation of the Hedgehog signaling pathway in T-lineage cells inhibits TCR repertoire selection in the thymus and peripheral T-cell activation
por: Rowbotham, Nicola J., et al.
Publicado: (2007)

Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells
por: Law, Helen K.W., et al.
Publicado: (2005)

TCRζ(dim)lymphocytes define populations of circulating effector cells that migrate to inflamed tissues
por: Zhang, Zhuoli, et al.
Publicado: (2007)

Novel biphasic role for lymphocytes revealed during resolving inflammation
por: Rajakariar, Ravindra, et al.
Publicado: (2008)

Evidence of dysregulation of dendritic cells in primary HIV infection
por: Sabado, Rachel Lubong, et al.
Publicado: (2010)

BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1–driven Immune Phenotypes with Distinct Spatial Orchestration
por: Bady, Elena, et al.
Publicado: (2023)

Newly-Discovered Neural Features Expand the Pathobiological Knowledge of Blastic Plasmacytoid Dendritic Cell Neoplasm
por: Sapienza, Maria Rosaria, et al.
Publicado: (2021)

MLL1 is central to macrophage-mediated inflammation
por: Schaller, Matthew A.
Publicado: (2023)

NR1H3 (LXRα) is associated with pro‐inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b‐cell lymphoma
por: Vegliante, Maria Carmela, et al.
Publicado: (2022)

Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis
por: Lecomte, Sara, et al.
Publicado: (2023)

Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseases
por: Martin Merinero, Héctor, et al.
Publicado: (2021)

4-1BBL–containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells
por: Swatler, Julian, et al.
Publicado: (2022)

The histone methyltransferase MLL1/KMT2A in monocytes drives coronavirus-associated coagulopathy and inflammation
por: Sharma, Sriganesh B., et al.
Publicado: (2023)

A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trials
por: Silbert, Sara K., et al.
Publicado: (2023)

Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration
por: Nicolai, Leo, et al.
Publicado: (2022)

SECTM1-based CAR T cells enriched with CD7-low/negative subsets exhibit efficacy in CD7-positive malignancies
por: Wei, Wenwen, et al.
Publicado: (2023)

Hypermethylation at the CXCR5 gene locus limits trafficking potential of CD8(+) T cells into B-cell follicles during HIV-1 infection
por: Ogunshola, Funsho J., et al.
Publicado: (2022)

Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse
por: Berdel, Andrew F., et al.
Publicado: (2022)

GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT
por: Wang, Dongyao, et al.
Publicado: (2022)

TOSCA: an automated Tumor Only Somatic CAlling workflow for somatic mutation detection without matched normal samples
por: Del Corvo, Marcello, et al.
Publicado: (2022)

Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1
por: Palmerini, Emanuela, et al.
Publicado: (2017)

Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature
por: Tabanelli, Valentina, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2ao7tsbbe1io5t0mtae6h7l9ng